SECTION 310:565-1-5. Reporting of tests by laboratories

  Any superintendent or manager of a laboratory performing tests for gonorrhea, syphilis, chancroid, Donovanosis (granuloma inguinale), lymphogranuloma venereum, or any other sexually transmissible disease which the State Commissioner of Health deems amenable to control, shall report testing activity to the State Venereal Disease Control Program or the local health officer according to the specifications in this section.

(1)   Method and Time Requirements.

(a)   A report will be completed in writing and submitted in sealed envelope on forms provided by the Commissioner at the end of each testing week at a minimum. Any positive or reactive tests will be reported as in 2.E-G contained in this section.

(b)   Quantative reagin tests for syphilis with a reactive titer of 1:8 or more on persons aged 0-40 years, and microscopic identification of Treponema pallidum (darkfield test) will be reported by collect telephone call in addition to entry on the written report.

(2)   Information Requirements. Report forms (ODH 235) are to be completed with the information contained in this section.

(a)   Laboratory identification (name, address, telephone number).

(b)   Signature of laboratory manager or designate.

(c)   Date of report and period covered.

(d)   Indication that no tests were positive when this is the fact.

(e)   Type of test, date performed, and complete result.

(f)   Name and telephone number of physician or health provider. (In those testing situations where no responsible physician or health provider can be identified, enter the address and telephone number of the person tested.)

(3)   Confidentiality of Reports. All reports of positive or reactive tests shall be considered confidential by the Oklahoma State Department of Health as described in Title 63, Article 5, Section 532 of the Public Health Code.

(4)   Consultation with Physicians. The State Commissioner of Health, the local health officer, or authorized agents under their supervision, shall consult with the physician or health provider requesting the test before instituting measures to prevent the spread of disease. All positive or reactive serologic test reports will be considered as suggestive of the presence of disease only and will not be considered as representing a diagnosis or a report of morbidity.